Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg M Cole

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
The Lancet. Neurology|January 22, 2008
Current and future uses of neuroimaging for cognitively impaired patientsGary W Small, Susan Y Bookheimer, Paul M Thompson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 14, 2004
Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease interventionLixia Zhao, Bruce Teter, Takashi Morihara, et al.
Dementia and Geriatric Cognitive Disorders|February 21, 2012
Cerebrospinal fluid biomarkers and proximity to diagnosis in preclinical familial Alzheimer's diseaseJohn M Ringman, Giovanni Coppola, David Elashoff, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 25, 2005
A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse modelGiselle P Lim, Frédéric Calon, Takashi Morihara, et al.
Neurobiology of Aging|November 4, 2005
Prevention of Alzheimer's disease: Omega-3 fatty acid and phenolic anti-oxidant interventionsGreg M Cole, Giselle P Lim, Fusheng Yang, et al.
Archives of Neurology|June 13, 2012
Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotypeJohn M Ringman, David Elashoff, Daniel H Geschwind, et al.
Molecular Immunology|March 6, 2003
Cell type specific targeted intracellular delivery into muscle of a monoclonal antibody that binds myosin IIbRichard H Weisbart, Fusheng Yang, Grace Chan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 28, 2007
Omega-3 fatty acid docosahexaenoic acid increases SorLA/LR11, a sorting protein with reduced expression in sporadic Alzheimer's disease (AD): relevance to AD preventionQiu-Lan Ma, Bruce Teter, Oliver J Ubeda, et al.
The Journal of Biological Chemistry|March 19, 2008
p21-activated kinase-aberrant activation and translocation in Alzheimer disease pathogenesisQiu-Lan Ma, Fusheng Yang, Frédéric Calon, et al.
Journal of Neurochemistry|September 1, 2007
Evidence of Abeta- and transgene-dependent defects in ERK-CREB signaling in Alzheimer's modelsQiu-Lan Ma, Marni E Harris-White, Oliver J Ubeda, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
The Lancet. Neurology|January 22, 2008
Current and future uses of neuroimaging for cognitively impaired patientsGary W Small, Susan Y Bookheimer, Paul M Thompson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 14, 2004
Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease interventionLixia Zhao, Bruce Teter, Takashi Morihara, et al.
Dementia and Geriatric Cognitive Disorders|February 21, 2012
Cerebrospinal fluid biomarkers and proximity to diagnosis in preclinical familial Alzheimer's diseaseJohn M Ringman, Giovanni Coppola, David Elashoff, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 25, 2005
A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse modelGiselle P Lim, Frédéric Calon, Takashi Morihara, et al.
Neurobiology of Aging|November 4, 2005
Prevention of Alzheimer's disease: Omega-3 fatty acid and phenolic anti-oxidant interventionsGreg M Cole, Giselle P Lim, Fusheng Yang, et al.
Archives of Neurology|June 13, 2012
Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotypeJohn M Ringman, David Elashoff, Daniel H Geschwind, et al.
Molecular Immunology|March 6, 2003
Cell type specific targeted intracellular delivery into muscle of a monoclonal antibody that binds myosin IIbRichard H Weisbart, Fusheng Yang, Grace Chan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 28, 2007
Omega-3 fatty acid docosahexaenoic acid increases SorLA/LR11, a sorting protein with reduced expression in sporadic Alzheimer's disease (AD): relevance to AD preventionQiu-Lan Ma, Bruce Teter, Oliver J Ubeda, et al.
The Journal of Biological Chemistry|March 19, 2008
p21-activated kinase-aberrant activation and translocation in Alzheimer disease pathogenesisQiu-Lan Ma, Fusheng Yang, Frédéric Calon, et al.
Journal of Neurochemistry|September 1, 2007
Evidence of Abeta- and transgene-dependent defects in ERK-CREB signaling in Alzheimer's modelsQiu-Lan Ma, Marni E Harris-White, Oliver J Ubeda, et al.
Pageof 5